Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) (Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF)) (Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF)) CEO, Jeremy Skillington and Chairman, Cathal Friel presenting at the One2One Forum 26th April 2022.
Poolbeg Pharma PLC is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables it to develop multiple products faster and more cost effectively than the traditional biotech model. The company has aspirations to become a “one-stop-shop” for Big Pharma seeking mid-stage products to license or acquire.